Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.
Meet the Vena MicroAngioscope: a world-first Canadian innovation giving neurosurgeons real-time, full-colour views from inside the brain’s blood vessels.